Supplements

Guidelines in Practice supplements provide expert opinion articles on a range of clinical and commissioning areas. Our supplement range includes the following types: Product Review; Guidance Update; Local Implementation. Items may contain pharmaceutical promotional information.

20210209 Takeda supplement V1 front cover image

Switching appropriate patients with type 2 diabetes to alogliptin from existing DPP-4 inhibitors: experience and outcomes from three Clinical Commissioning Groups and Local Health Boards

Commissioned by Takeda UK Ltd

Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by Takeda UK Ltd. It has been developed in partnership with Grey Bear Consultancy and published by Guidelines in Practice.
View prescribing information
C-APROM/UK/VIP/0326
Date of preparation: February 2021

Emollient supplement_Index image

Recommending emollients for patients with atopic dermatitis or dry skin conditions

Commissioned by L’Oréal (UK) Limited

This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines
Date of preparation: January 2021

Index image_Soprobec supplement_PI update

Practical tips for maintaining asthma care prompted by a supply issue during the COVID-19 pandemic

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This supplement has been commissioned and funded by Glenmark Pharmaceuticals Europe Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
PP-UK-SOP-0129 December 2020

Diabetes equipment vector

Showcasing local best practice in diabetes

This Guidelines in Practice supplement that aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care:

Leeds supplement_digital_index image

Managing patients with type 2 diabetes— a cardiometabolic pathway for a cardiovascular risk reduction approach

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This supplement has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice.
View prescribing and adverse event reporting information
PC-GB-103153 November 2020

Celltrion supplement cover

Switching from intravenous to subcutaneous infliximab biosimilar (Remsima®) in adult patients with inflammatory bowel disease: experience at an NHS trust

Commissioned by Celltrion Healthcare UK Ltd

This supplement has been commissioned and funded by Celltrion Healthcare UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
CTHC-UK-219D (1) October 2020

FINAL Psoriasis supplement index image

High cost drugs in psoriasis: how to optimise patient care and budgets

Commissioned by Almirall Ltd

This supplement has been commissioned and funded by Almirall Ltd and developed in partnership with Guidelines in Practice. Information intended for UK healthcare professionals only.
UK-NOP-2000055

Optimised patient pathway for infertility

An optimised patient pathway for the treatment of heterosexual patients with infertility

Commissioned by Merck Serono Ltd

This supplement has been commissioned and funded by Merck Serono Ltd and developed in partnership with Guidelines in Practice.

Malnutrition supplement

Identification and management of patients with malnutrition

Commissioned by Alliance Pharmaceuticals Ltd

This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.

20200311 DPP-4 inhibitor GinP supplement v10 digital version draft

Choosing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and co‑morbidities

Commissioned by Boehringer Ingelheim Limited

This supplement has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.

ICS consensus

How should inhaled steroids be used in the management of asthma in adults within a primary care setting?

Supported by an educational grant from CIPLA EU Ltd

Information intended for healthcare professionals only.

Biosimilar insulin WPG

Guideline for the managed introduction of biosimilar basal insulin

Supported by an educational grant from Mylan

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.